|Solubility:||DMSO ≥100 mg/mL|
|Long-term Storage:||at -20℃|
|HPLC:||Shows Min 99.29% purity|
|H-NMR:||Consistent with structure|
|Description:||RAF265 is a novel, orally bioavailable dual inhibitor of RAF kinase and VEGFR2.|
|Stability and Solubility Advice:|| Information concerning product stability, particularly in solution, has rarely been reported and in most cases we can only offer a general guide.
We recommend that stock solutions, once prepared, are stored aliquoted in tightly sealed vials at -20°C or below and used within 1 month.